Statement Of Cash Flows [Abstract]

Carl Zeiss Meditec AG - Filing #7003358

Concept	As at 2021-09-30	2020-10-01 to 2021-09-30	2019-10-01 to 2020-09-30	As at 2020-09-30	As at 2019-09-30
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Interest paid, classified as operating activities	—	1,629 EUR	1,365 EUR	—	—
Income taxes paid (refund), classified as operating activities	—	97,908 EUR	58,964 EUR	—	—
Cash flows from (used in) operating activities	—	362,663 EUR	178,527 EUR	—	—
Cash flows from (used in) investing activities [abstract]
Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities	—	11,509 EUR	26,227 EUR	—	—
Other cash receipts from sales of equity or debt instruments of other entities, classified as investing activities	—	—	163,000 EUR	—	—
Other cash payments to acquire equity or debt instruments of other entities, classified as investing activities	—	2,416 EUR	25,000 EUR	—	—
Purchase of property, plant and equipment, classified as investing activities	—	30,122 EUR	29,325 EUR	—	—
Purchase of intangible assets, classified as investing activities	—	35,979 EUR	15,661 EUR	—	—
Cash flows from (used in) investing activities	—	75,200 EUR	70,947 EUR	—	—
Cash flows from (used in) financing activities [abstract]
Payments of lease liabilities, classified as financing activities	—	17,727 EUR	16,077 EUR	—	—
Cash flows from (used in) financing activities	—	285,889 EUR	122,961 EUR	—	—
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents	—	337,000 EUR	1,056 EUR	—	—
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes	—	1,237 EUR	16,437 EUR	—	—
Cash and cash equivalents	7,439 EUR	—	—	6,202 EUR	22,639 EUR